| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.861 | 0.005 | 0.861 | Caspase 9 stimulant | 0.692 0.025 CID_6246154 0.692 0.025 CID_5356421 | ||
| 0.859 | 0.004 | 0.859 | Platelet antagonist | 0.835 0.004 CID_6246154 0.835 0.004 CID_5356421 | ||
| 0.815 | 0.004 | 0.815 | Cholesterol antagonist | 0.687 0.009 CID_6246154 0.687 0.009 CID_5356421 | ||
| 0.817 | 0.013 | 0.817 | Antiinflammatory | 0.771 0.019 CID_6246154 0.771 0.019 CID_5356421 | ||
| 0.772 | 0.004 | 0.772 | Vasodilator, peripheral | 0.658 0.009 CID_6246154 0.658 0.009 CID_5356421 | ||
| 0.736 | 0.004 | 0.872 | Angiogenesis stimulant | 0.872 0.003 CID_6246154 0.872 0.003 CID_5356421 | CID_5356421 | |
| 0.733 | 0.011 | 0.733 | Cyclophilin D inhibitor | 0.618 0.024 CID_6246154 0.618 0.024 CID_5356421 | ||
| 0.716 | 0.007 | 0.853 | Antithrombotic | 0.853 0.003 CID_6246154 0.853 0.003 CID_5356421 | CID_5356421 | |
| 0.683 | 0.005 | 0.683 | Hypolipemic | 0.604 0.006 CID_6246154 0.604 0.006 CID_5356421 | ||
| 0.675 | 0.005 | 0.675 | Apoptosis antagonist | 0.482 0.023 CID_6246154 0.482 0.023 CID_5356421 | ||
| 0.659 | 0.002 | 0.659 | GABA C receptor agonist | 0.336 0.007 CID_6246154 0.336 0.007 CID_5356421 | ||
| 0.648 | 0.005 | 0.753 | Platelet aggregation inhibitor | 0.753 0.004 CID_6246154 0.753 0.004 CID_5356421 | CID_5356421 | |
| 0.63 | 0.002 | 0.63 | Succinate dehydrogenase inhibitor | 0.351 0.005 CID_6246154 0.351 0.005 CID_5356421 | ||
| 0.614 | 0.004 | 0.614 | Phospholipase C inhibitor | 0.452 0.008 CID_6246154 0.452 0.008 CID_5356421 | ||
| 0.603 | 0.006 | 0.716 | Vasodilator | 0.716 0.004 CID_6246154 0.716 0.004 CID_5356421 | CID_5356421 | |
| 0.63 | 0.043 | 0.668 | Apoptosis agonist | 0.668 0.036 CID_6246154 0.668 0.036 CID_5356421 | CID_5356421 | |
| 0.588 | 0.004 | 0.588 | Aldehyde dehydrogenase inhibitor | 0.26 0.016 CID_6246154 0.26 0.016 CID_5356421 | ||
| 0.575 | 0.003 | 0.575 | Vanilloid agonist | 0.212 0.006 CID_6246154 0.212 0.006 CID_5356421 | ||
| 0.581 | 0.012 | 0.581 | Histamine release inhibitor | 0.478 0.037 CID_6246154 0.478 0.037 CID_5356421 | ||
| 0.56 | 0.004 | 0.748 | Platelet adhesion inhibitor | 0.748 0.003 CID_6246154 0.748 0.003 CID_5356421 | CID_5356421 | |
| 0.564 | 0.01 | 0.564 | Hypoglycemic | 0.492 0.016 CID_6246154 0.492 0.016 CID_5356421 | ||
| 0.556 | 0.016 | 0.556 | Immunomodulator | 0.273 0.098 CID_6246154 0.273 0.098 CID_5356421 | ||
| 0.556 | 0.019 | 0.559 | Immunosuppressant | 0.559 0.019 CID_6246154 0.559 0.019 CID_5356421 | CID_5356421 | |
| 0.539 | 0.005 | 0.539 | Alpha-N-acetylglucosaminidase inhibitor | 0.321 0.014 CID_6246154 0.321 0.014 CID_5356421 | ||
| 0.565 | 0.036 | 0.565 | Transcription factor NF kappa B inhibitor | 0.544 0.038 CID_6246154 0.544 0.038 CID_5356421 | ||
| 0.547 | 0.026 | 0.547 | Aldehyde oxidase inhibitor | 0.146 0.143 CID_6246154 0.146 0.143 CID_5356421 | ||
| 0.52 | 0.006 | 0.52 | Interleukin 2 agonist | 0.462 0.013 CID_6246154 0.462 0.013 CID_5356421 | ||
| 0.522 | 0.016 | 0.616 | Lipoxygenase inhibitor | 0.616 0.009 CID_6246154 0.616 0.009 CID_5356421 | CID_5356421 | |
| 0.507 | 0.004 | 0.507 | 5 Hydroxytryptamine uptake stimulant | 0.347 0.026 CID_6246154 0.347 0.026 CID_5356421 | ||
| 0.523 | 0.02 | 0.523 | GABA C receptor rho-3 antagonist | 0.241 0.162 CID_6246154 0.241 0.162 CID_5356421 | ||
| 0.507 | 0.004 | 0.622 | Protein kinase stimulant | 0.622 0.002 CID_6246154 0.622 0.002 CID_5356421 | CID_5356421 | |
| 0.508 | 0.019 | 0.508 | Caspase 3 stimulant | 0.302 0.078 CID_6246154 0.302 0.078 CID_5356421 | ||
| 0.492 | 0.004 | 0.492 | Phospholipase A2 inhibitor | 0.39 0.005 CID_6246154 0.39 0.005 CID_5356421 | ||
| 0.489 | 0.007 | 0.489 | Non-steroidal antiinflammatory agent | 0.295 0.029 CID_6246154 0.295 0.029 CID_5356421 | ||
| 0.501 | 0.029 | 0.501 | Immunostimulant | 0.481 0.031 CID_6246154 0.481 0.031 CID_5356421 | ||
| 0.481 | 0.01 | 0.481 | Interleukin agonist | 0.38 0.022 CID_6246154 0.38 0.022 CID_5356421 | ||
| 0.474 | 0.004 | 0.474 | Tyrosine 3 hydroxylase inhibitor | 0.298 0.034 CID_6246154 0.298 0.034 CID_5356421 | ||
| 0.472 | 0.004 | 0.472 | Gastrin inhibitor | 0.403 0.005 CID_6246154 0.403 0.005 CID_5356421 | ||
| 0.495 | 0.028 | 0.495 | 5 Hydroxytryptamine release stimulant | 0.266 0.082 CID_6246154 0.266 0.082 CID_5356421 | ||
| 0.467 | 0.004 | 0.467 | Insulin sensitizer | 0.332 0.011 CID_6246154 0.332 0.011 CID_5356421 | ||
| 0.492 | 0.035 | 0.492 | 5 Hydroxytryptamine release inhibitor | 0.398 0.079 CID_6246154 0.398 0.079 CID_5356421 | ||
| 0.482 | 0.026 | 0.482 | Spasmolytic | 0.273 0.081 CID_6246154 0.273 0.081 CID_5356421 | ||
| 0.455 | 0.003 | 0.455 | Ferrochelatase inhibitor | 0.258 0.012 CID_6246154 0.258 0.012 CID_5356421 | ||
| 0.475 | 0.023 | 0.475 | Antioxidant | 0.317 0.056 CID_6246154 0.317 0.056 CID_5356421 | ||
| 0.45 | 0.002 | 0.45 | Adenylate kinase inhibitor | 0.382 0.004 CID_6246154 0.382 0.004 CID_5356421 | ||
| 0.456 | 0.011 | 0.456 | Anesthetic general | 0.373 0.02 CID_6246154 0.373 0.02 CID_5356421 | ||
| 0.444 | 0.004 | 0.444 | TRPA1 agonist | 0.214 0.008 CID_6246154 0.214 0.008 CID_5356421 | ||
| 0.442 | 0.004 | 0.442 | Prostaglandin EP2 antagonist | 0.396 0.004 CID_6246154 0.396 0.004 CID_5356421 | ||
| 0.44 | 0.004 | 0.44 | Porphobilinogen synthase inhibitor | 0.116 0.03 CID_6246154 0.116 0.03 CID_5356421 | ||
| 0.429 | 0.004 | 0.429 | Prostaglandin antagonist | 0.319 0.005 CID_6246154 0.319 0.005 CID_5356421 | ||
| 0.426 | 0.011 | 0.426 | Sodium/bile acid cotransporter inhibitor | 0.383 0.023 CID_6246154 0.383 0.023 CID_5356421 | ||
| 0.419 | 0.005 | 0.419 | Cell adhesion inhibitor | 0.342 0.008 CID_6246154 0.342 0.008 CID_5356421 | ||
| 0.41 | 0.003 | 0.41 | Vanilloid 1 agonist | 0.224 0.008 CID_6246154 0.224 0.008 CID_5356421 | ||
| 0.42 | 0.023 | 0.42 | Superoxide dismutase inhibitor | 0.176 0.147 CID_6246154 0.176 0.147 CID_5356421 | ||
| 0.439 | 0.047 | 0.439 | Toll-Like receptor agonist | 0.27 0.131 CID_6246154 0.27 0.131 CID_5356421 | ||
| 0.404 | 0.015 | 0.404 | Growth hormone agonist | 0.342 0.025 CID_6246154 0.342 0.025 CID_5356421 | ||
| 0.443 | 0.059 | 0.545 | Antibacterial | 0.545 0.03 CID_6246154 0.545 0.03 CID_5356421 | CID_5356421 | |
| 0.439 | 0.058 | 0.439 | 15-Lipoxygenase inhibitor | 0.282 0.142 CID_6246154 0.282 0.142 CID_5356421 | ||
| 0.381 | 0.002 | 0.381 | Prolactin inhibitor | 0.226 0.005 CID_6246154 0.226 0.005 CID_5356421 | ||
| 0.405 | 0.03 | 0.405 | Interleukin antagonist | 0.378 0.034 CID_6246154 0.378 0.034 CID_5356421 | ||
| 0.379 | 0.006 | 0.379 | 5-Lipoxygenase inhibitor | 0.221 0.02 CID_6246154 0.221 0.02 CID_5356421 | ||
| 0.375 | 0.003 | 0.375 | Toll-Like receptor 2 antagonist | 0.222 0.015 CID_6246154 0.222 0.015 CID_5356421 | ||
| 0.382 | 0.01 | 0.382 | Lipid peroxidase inhibitor | 0.18 0.05 CID_6246154 0.18 0.05 CID_5356421 | ||
| 0.375 | 0.004 | 0.375 | Catalase inhibitor | 0.263 0.008 CID_6246154 0.263 0.008 CID_5356421 | ||
| 0.392 | 0.022 | 0.392 | Peroxidase inhibitor | 0.196 0.06 CID_6246154 0.196 0.06 CID_5356421 | ||
| 0.373 | 0.004 | 0.373 | Glutamate dehydrogenase inhibitor | 0.189 0.011 CID_6246154 0.189 0.011 CID_5356421 | ||
| 0.369 | 0.003 | 0.399 | Prostaglandin F2 alpha antagonist | 0.399 0.002 CID_6246154 0.399 0.002 CID_5356421 | CID_5356421 | |
| 0.385 | 0.024 | 0.385 | DNA synthesis inhibitor | 0.326 0.036 CID_6246154 0.326 0.036 CID_5356421 | ||
| 0.375 | 0.016 | 0.375 | Hepatoprotectant | 0.258 0.041 CID_6246154 0.258 0.041 CID_5356421 | ||
| 0.368 | 0.013 | 0.368 | Monophenol monooxygenase inhibitor | 0.17 0.04 CID_6246154 0.17 0.04 CID_5356421 | ||
| 0.359 | 0.005 | 0.359 | Mediator release inhibitor | 0.194 0.016 CID_6246154 0.194 0.016 CID_5356421 | ||
| 0.354 | 0.004 | 0.354 | Phosphofructokinase-1 inhibitor | 0.304 0.005 CID_6246154 0.304 0.005 CID_5356421 | ||
| 0.352 | 0.004 | 0.352 | Alcohol oxidase inhibitor | 0.067 0.03 CID_6246154 0.067 0.03 CID_5356421 | ||
| 0.354 | 0.008 | 0.354 | DNA polymerase I inhibitor | 0.297 0.011 CID_6246154 0.297 0.011 CID_5356421 | ||
| 0.349 | 0.004 | 0.349 | Triose-phosphate isomerase inhibitor | 0.227 0.008 CID_6246154 0.227 0.008 CID_5356421 | ||
| 0.346 | 0.002 | 0.346 | Aconitate hydratase inhibitor | 0.131 0.005 CID_6246154 0.131 0.005 CID_5356421 | ||
| 0.373 | 0.032 | 0.373 | Tumour necrosis factor alpha release inhibitor | 0.231 0.085 CID_6246154 0.231 0.085 CID_5356421 | ||
| 0.343 | 0.004 | 0.343 | Peroxisome proliferator-activated receptor gamma agonist | 0.195 0.007 CID_6246154 0.195 0.007 CID_5356421 | ||
| 0.361 | 0.023 | 0.361 | RNA-directed DNA polymerase inhibitor | 0.238 0.057 CID_6246154 0.238 0.057 CID_5356421 | ||
| 0.401 | 0.065 | 0.401 | Antiobesity | |||
| 0.334 | 0.003 | 0.334 | Glycine transporter 2 inhibitor | 0.078 0.018 CID_6246154 0.078 0.018 CID_5356421 | ||
| 0.343 | 0.013 | 0.343 | Protein-tyrosine phosphatase inhibitor | 0.242 0.033 CID_6246154 0.242 0.033 CID_5356421 | ||
| 0.344 | 0.017 | 0.344 | Melanin inhibitor | 0.259 0.027 CID_6246154 0.259 0.027 CID_5356421 | ||
| 0.327 | 0.007 | 0.42 | Interleukin 4 antagonist | 0.42 0.005 CID_6246154 0.42 0.005 CID_5356421 | CID_5356421 | |
| 0.321 | 0.004 | 0.321 | Transcription factor NF kappa B stimulant | 0.145 0.017 CID_6246154 0.145 0.017 CID_5356421 | ||
| 0.319 | 0.002 | 0.319 | Lysophosphatidic acid 2 receptor antagonist | 0.107 0.004 CID_6246154 0.107 0.004 CID_5356421 | ||
| 0.326 | 0.01 | 0.326 | Insulin secretagoues | 0.14 0.085 CID_6246154 0.14 0.085 CID_5356421 | ||
| 0.321 | 0.005 | 0.321 | Catenin beta inhibitor | 0.163 0.078 CID_6246154 0.163 0.078 CID_5356421 | ||
| 0.32 | 0.005 | 0.32 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.24 0.011 CID_6246154 0.24 0.011 CID_5356421 | ||
| 0.317 | 0.003 | 0.317 | Glutamate decarboxylase inhibitor | 0.145 0.014 CID_6246154 0.145 0.014 CID_5356421 | ||
| 0.381 | 0.068 | 0.381 | Toll-Like receptor 7 agonist | 0.231 0.166 CID_6246154 0.231 0.166 CID_5356421 | ||
| 0.327 | 0.016 | 0.345 | Interferon gamma antagonist | 0.345 0.014 CID_6246154 0.345 0.014 CID_5356421 | CID_5356421 | |
| 0.324 | 0.015 | 0.344 | Bone formation stimulant | 0.344 0.013 CID_6246154 0.344 0.013 CID_5356421 | CID_5356421 | |
| 0.327 | 0.02 | 0.327 | Thrombolytic | 0.228 0.04 CID_6246154 0.228 0.04 CID_5356421 | ||
| 0.306 | 0.003 | 0.306 | Fumarate hydratase inhibitor | 0.117 0.005 CID_6246154 0.117 0.005 CID_5356421 | ||
| 0.311 | 0.009 | 0.311 | Cystathionine beta-synthase inhibitor | 0.212 0.022 CID_6246154 0.212 0.022 CID_5356421 | ||
| 0.336 | 0.034 | 0.336 | Psychostimulant | 0.175 0.096 CID_6246154 0.175 0.096 CID_5356421 | ||
| 0.337 | 0.039 | 0.337 | Insulysin inhibitor | 0.217 0.132 CID_6246154 0.217 0.132 CID_5356421 | ||
| 0.299 | 0.002 | 0.326 | Prostaglandin agonist | 0.326 0.002 CID_6246154 0.326 0.002 CID_5356421 | CID_5356421 | |
| 0.314 | 0.019 | 0.314 | Lipocortins synthesis antagonist | 0.23 0.041 CID_6246154 0.23 0.041 CID_5356421 | ||
| 0.303 | 0.011 | 0.31 | Cholesterol synthesis inhibitor | 0.31 0.01 CID_6246154 0.31 0.01 CID_5356421 | CID_5356421 | |
| 0.307 | 0.021 | 0.307 | Diuretic | |||
| 0.298 | 0.013 | 0.298 | Alkylator | 0.169 0.037 CID_6246154 0.169 0.037 CID_5356421 | ||
| 0.343 | 0.06 | 0.343 | 12-Lipoxygenase inhibitor | |||
| 0.285 | 0.002 | 0.285 | Arachidonic acid antagonist | 0.258 0.004 CID_6246154 0.258 0.004 CID_5356421 | ||
| 0.306 | 0.024 | 0.306 | DNA methyltransferase I inhibitor | 0.141 0.114 CID_6246154 0.141 0.114 CID_5356421 | ||
| 0.296 | 0.015 | 0.296 | Antipruritic | 0.234 0.03 CID_6246154 0.234 0.03 CID_5356421 | ||
| 0.285 | 0.004 | 0.285 | Leukotriene antagonist | 0.247 0.004 CID_6246154 0.247 0.004 CID_5356421 | ||
| 0.326 | 0.045 | 0.326 | Free radical scavenger | 0.236 0.075 CID_6246154 0.236 0.075 CID_5356421 | ||
| 0.317 | 0.037 | 0.317 | Nitric oxide antagonist | 0.202 0.066 CID_6246154 0.202 0.066 CID_5356421 | ||
| 0.282 | 0.005 | 0.282 | Photosensitizer | 0.21 0.011 CID_6246154 0.21 0.011 CID_5356421 | ||
| 0.275 | 0.003 | 0.275 | Adenylate cyclase stimulant | 0.222 0.007 CID_6246154 0.222 0.007 CID_5356421 | ||
| 0.275 | 0.005 | 0.294 | Cell adhesion molecule inhibitor | 0.294 0.005 CID_6246154 0.294 0.005 CID_5356421 | CID_5356421 | |
| 0.281 | 0.011 | 0.281 | Cell wall synthesis inhibitor | 0.163 0.054 CID_6246154 0.163 0.054 CID_5356421 | ||
| 0.289 | 0.021 | 0.289 | Neurotrophic factor enhancer | 0.23 0.051 CID_6246154 0.23 0.051 CID_5356421 | ||
| 0.268 | 0.005 | 0.268 | GABA C receptor antagonist | 0.119 0.053 CID_6246154 0.119 0.053 CID_5356421 | ||
| 0.267 | 0.005 | 0.267 | Carbamoyl phosphate synthetase inhibitor | 0.159 0.01 CID_6246154 0.159 0.01 CID_5356421 | ||
| 0.265 | 0.004 | 0.265 | Thioredoxin inhibitor | 0.174 0.011 CID_6246154 0.174 0.011 CID_5356421 | ||
| 0.274 | 0.013 | 0.274 | Protein-tyrosine phosphatase 1B inhibitor | 0.196 0.03 CID_6246154 0.196 0.03 CID_5356421 | ||
| 0.326 | 0.068 | 0.326 | Vasodilator, coronary | 0.273 0.111 CID_6246154 0.273 0.111 CID_5356421 | ||
| 0.26 | 0.003 | 0.26 | Acyl-CoA dehydrogenase inhibitor | 0.209 0.005 CID_6246154 0.209 0.005 CID_5356421 | ||
| 0.256 | 0.003 | 0.256 | Thromboxane synthase inhibitor | 0.146 0.004 CID_6246154 0.146 0.004 CID_5356421 | ||
| 0.255 | 0.005 | 0.255 | Argininosuccinate synthase inhibitor | 0.154 0.011 CID_6246154 0.154 0.011 CID_5356421 | ||
| 0.246 | 0.004 | 0.246 | CDC25A inhibitor | 0.187 0.008 CID_6246154 0.187 0.008 CID_5356421 | ||
| 0.275 | 0.036 | 0.275 | DNA methylase inhibitor | 0.158 0.11 CID_6246154 0.158 0.11 CID_5356421 | ||
| 0.24 | 0.003 | 0.24 | Sphingosine 1-phosphate receptor 4 agonist | 0.152 0.008 CID_6246154 0.152 0.008 CID_5356421 | ||
| 0.248 | 0.013 | 0.248 | Expectorant | 0.153 0.034 CID_6246154 0.153 0.034 CID_5356421 | ||
| 0.239 | 0.003 | 0.239 | Thromboxane antagonist | 0.16 0.004 CID_6246154 0.16 0.004 CID_5356421 | ||
| 0.268 | 0.035 | 0.268 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.22 0.058 CID_6246154 0.22 0.058 CID_5356421 | ||
| 0.29 | 0.058 | 0.29 | Transcription factor STAT3 inhibitor | |||
| 0.234 | 0.003 | 0.234 | Glycine receptor agonist | 0.154 0.006 CID_6246154 0.154 0.006 CID_5356421 | ||
| 0.257 | 0.026 | 0.257 | Amylase inhibitor | 0.13 0.075 CID_6246154 0.13 0.075 CID_5356421 | ||
| 0.234 | 0.004 | 0.234 | Sphingosine 1-phosphate receptor 2 antagonist | 0.186 0.012 CID_6246154 0.186 0.012 CID_5356421 | ||
| 0.234 | 0.005 | 0.234 | Leukotriene synthesis inhibitor | 0.164 0.008 CID_6246154 0.164 0.008 CID_5356421 | ||
| 0.233 | 0.004 | 0.233 | Ornithine decarboxylase inhibitor | 0.21 0.004 CID_6246154 0.21 0.004 CID_5356421 | ||
| 0.231 | 0.003 | 0.231 | Vanilloid 2 antagonist | 0.079 0.009 CID_6246154 0.079 0.009 CID_5356421 | ||
| 0.289 | 0.062 | 0.289 | Transcription factor STAT inhibitor | |||
| 0.23 | 0.006 | 0.23 | Keratolytic | 0.096 0.033 CID_6246154 0.096 0.033 CID_5356421 | ||
| 0.232 | 0.008 | 0.232 | Mucolytic | 0.166 0.024 CID_6246154 0.166 0.024 CID_5356421 | ||
| 0.227 | 0.005 | 0.227 | Sphingosine 1-phosphate receptor 5 antagonist | 0.174 0.03 CID_6246154 0.174 0.03 CID_5356421 | ||
| 0.226 | 0.005 | 0.226 | GABA C receptor rho-1 antagonist | 0.107 0.053 CID_6246154 0.107 0.053 CID_5356421 | ||
| 0.223 | 0.002 | 0.223 | Ca2+-transporting ATPase inhibitor | 0.193 0.004 CID_6246154 0.193 0.004 CID_5356421 | ||
| 0.229 | 0.009 | 0.229 | Alcohol dehydrogenase inhibitor | 0.134 0.026 CID_6246154 0.134 0.026 CID_5356421 | ||
| 0.224 | 0.006 | 0.224 | Toll-Like receptor 2 agonist | 0.126 0.013 CID_6246154 0.126 0.013 CID_5356421 | ||
| 0.217 | 0.003 | 0.217 | Thromboxane A2 antagonist | 0.15 0.004 CID_6246154 0.15 0.004 CID_5356421 | ||
| 0.213 | 0.003 | 0.213 | Leukotriene B4 antagonist | 0.198 0.004 CID_6246154 0.198 0.004 CID_5356421 | ||
| 0.235 | 0.026 | 0.447 | Interleukin 6 antagonist | 0.447 0.005 CID_6246154 0.447 0.005 CID_5356421 | CID_5356421 | |
| 0.216 | 0.008 | 0.216 | Folate antagonist | 0.148 0.023 CID_6246154 0.148 0.023 CID_5356421 | ||
| 0.225 | 0.016 | 0.225 | Aminopeptidase B inhibitor | 0.148 0.039 CID_6246154 0.148 0.039 CID_5356421 | ||
| 0.222 | 0.015 | 0.222 | Microtubule formation inhibitor | 0.197 0.02 CID_6246154 0.197 0.02 CID_5356421 | ||
| 0.226 | 0.021 | 0.238 | ATPase inhibitor | 0.238 0.017 CID_6246154 0.238 0.017 CID_5356421 | CID_5356421 | |
| 0.206 | 0.004 | 0.206 | Acetyl-CoA transferase inhibitor | 0.08 0.02 CID_6246154 0.08 0.02 CID_5356421 | ||
| 0.206 | 0.004 | 0.206 | Peroxisome proliferator-activated receptor alpha agonist | 0.101 0.012 CID_6246154 0.101 0.012 CID_5356421 | ||
| 0.209 | 0.008 | 0.209 | Sphingosine 1-phosphate receptor 4 antagonist | 0.145 0.038 CID_6246154 0.145 0.038 CID_5356421 | ||
| 0.217 | 0.021 | 0.217 | Neurotrophic factor | 0.2 0.028 CID_6246154 0.2 0.028 CID_5356421 | ||
| 0.2 | 0.004 | 0.2 | Leukotriene D4 antagonist | 0.069 0.008 CID_6246154 0.069 0.008 CID_5356421 | ||
| 0.203 | 0.008 | 0.203 | Electrolyte absorption antagonist | 0.106 0.049 CID_6246154 0.106 0.049 CID_5356421 | ||
| 0.212 | 0.018 | 0.212 | Farnesoid X receptor antagonist | 0.169 0.035 CID_6246154 0.169 0.035 CID_5356421 | ||
| 0.196 | 0.002 | 0.196 | Lysophosphatidic acid 3 receptor antagonist | 0.137 0.003 CID_6246154 0.137 0.003 CID_5356421 | ||
| 0.219 | 0.027 | 0.219 | Hemostatic | 0.191 0.037 CID_6246154 0.191 0.037 CID_5356421 | ||
| 0.201 | 0.009 | 0.201 | Sphingomyelinase inhibitor | 0.173 0.016 CID_6246154 0.173 0.016 CID_5356421 | ||
| 0.193 | 0.003 | 0.196 | Prostaglandin E2 agonist | 0.196 0.003 CID_6246154 0.196 0.003 CID_5356421 | CID_5356421 | |
| 0.2 | 0.009 | 0.2 | Caspase 3 inhibitor | 0.111 0.073 CID_6246154 0.111 0.073 CID_5356421 | ||
| 0.2 | 0.01 | 0.2 | Creatine kinase inhibitor | 0.087 0.077 CID_6246154 0.087 0.077 CID_5356421 | ||
| 0.192 | 0.002 | 0.192 | Glucose-6-phosphate isomerase inhibitor | 0.136 0.003 CID_6246154 0.136 0.003 CID_5356421 | ||
| 0.203 | 0.013 | 0.203 | Calcium antagonist | 0.085 0.06 CID_6246154 0.085 0.06 CID_5356421 | ||
| 0.2 | 0.011 | 0.24 | Selectin antagonist | 0.24 0.009 CID_6246154 0.24 0.009 CID_5356421 | CID_5356421 | |
| 0.194 | 0.006 | 0.194 | Amidase inhibitor | |||
| 0.192 | 0.005 | 0.192 | Anabolic | 0.163 0.012 CID_6246154 0.163 0.012 CID_5356421 | ||
| 0.193 | 0.007 | 0.193 | Toll-Like receptor 4 antagonist | 0.162 0.015 CID_6246154 0.162 0.015 CID_5356421 | ||
| 0.197 | 0.011 | 0.197 | AMP-activated protein kinase stimulant | 0.107 0.062 CID_6246154 0.107 0.062 CID_5356421 | ||
| 0.191 | 0.006 | 0.211 | Interferon agonist | 0.211 0.005 CID_6246154 0.211 0.005 CID_5356421 | CID_5356421 | |
| 0.194 | 0.01 | 0.194 | Antimetabolite | 0.096 0.017 CID_6246154 0.096 0.017 CID_5356421 | ||
| 0.19 | 0.006 | 0.19 | Biliverdin reductase inhibitor | 0.098 0.019 CID_6246154 0.098 0.019 CID_5356421 | ||
| 0.188 | 0.004 | 0.188 | Sphingosine 1-phosphate receptor 5 agonist | 0.089 0.01 CID_6246154 0.089 0.01 CID_5356421 | ||
| 0.207 | 0.025 | 0.207 | GABA C receptor rho-2 antagonist | |||
| 0.185 | 0.007 | 0.185 | Ornithine carbamoyltransferase inhibitor | 0.093 0.018 CID_6246154 0.093 0.018 CID_5356421 | ||
| 0.183 | 0.005 | 0.183 | CDC25B inhibitor | 0.078 0.03 CID_6246154 0.078 0.03 CID_5356421 | ||
| 0.195 | 0.017 | 0.195 | Carbonic anhydrase III inhibitor | 0.109 0.053 CID_6246154 0.109 0.053 CID_5356421 | ||
| 0.187 | 0.01 | 0.437 | Electron transport complex I inhibitor | 0.437 0.004 CID_6246154 0.437 0.004 CID_5356421 | CID_5356421 | |
| 0.191 | 0.014 | 0.191 | Gastric antisecretory | 0.121 0.042 CID_6246154 0.121 0.042 CID_5356421 | ||
| 0.208 | 0.031 | 0.208 | Neurotensin receptor agonist | 0.146 0.11 CID_6246154 0.146 0.11 CID_5356421 | ||
| 0.18 | 0.005 | 0.18 | GABA aminotransferase inhibitor | 0.087 0.038 CID_6246154 0.087 0.038 CID_5356421 | ||
| 0.178 | 0.005 | 0.178 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.112 0.014 CID_6246154 0.112 0.014 CID_5356421 | ||
| 0.195 | 0.023 | 0.195 | Antibacterial (Helicobacter pylori) | 0.189 0.025 CID_6246154 0.189 0.025 CID_5356421 | ||
| 0.193 | 0.024 | 0.193 | Cathepsin H inhibitor | 0.152 0.045 CID_6246154 0.152 0.045 CID_5356421 | ||
| 0.173 | 0.004 | 0.173 | Glycine receptor antagonist | 0.129 0.014 CID_6246154 0.129 0.014 CID_5356421 | ||
| 0.216 | 0.048 | 0.233 | Dual specificity phosphatase inhibitor | 0.233 0.042 CID_6246154 0.233 0.042 CID_5356421 | CID_5356421 | |
| 0.185 | 0.018 | 0.185 | Potassium channel (Ca-activated) activator | 0.174 0.021 CID_6246154 0.174 0.021 CID_5356421 | ||
| 0.19 | 0.023 | 0.19 | Cyclooxygenase 3 inhibitor | 0.135 0.062 CID_6246154 0.135 0.062 CID_5356421 | ||
| 0.17 | 0.003 | 0.17 | Glutamate (mGluR6) antagonist | 0.108 0.008 CID_6246154 0.108 0.008 CID_5356421 | ||
| 0.164 | 0.003 | 0.164 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.045 0.012 CID_6246154 0.045 0.012 CID_5356421 | ||
| 0.168 | 0.007 | 0.168 | Lanosterol 14 alpha demethylase inhibitor | 0.129 0.023 CID_6246154 0.129 0.023 CID_5356421 | ||
| 0.159 | 0.005 | 0.159 | Oleamide hydrolase inhibitor | 0.056 0.023 CID_6246154 0.056 0.023 CID_5356421 | ||
| 0.155 | 0.002 | 0.185 | Prostaglandin D2 agonist | 0.185 0.002 CID_6246154 0.185 0.002 CID_5356421 | CID_5356421 | |
| 0.158 | 0.007 | 0.158 | NMDA receptor agonist | |||
| 0.153 | 0.002 | 0.153 | Leukotriene C antagonist | 0.144 0.003 CID_6246154 0.144 0.003 CID_5356421 | ||
| 0.152 | 0.004 | 0.152 | Prostaglandin EP4 antagonist | 0.095 0.005 CID_6246154 0.095 0.005 CID_5356421 | ||
| 0.269 | 0.125 | 0.269 | Calcium channel activator | |||
| 0.147 | 0.002 | 0.147 | Kainate receptor agonist | 0.083 0.004 CID_6246154 0.083 0.004 CID_5356421 | ||
| 0.154 | 0.01 | 0.257 | Potassium channel large-conductance Ca-activated activator | 0.257 0.005 CID_6246154 0.257 0.005 CID_5356421 | CID_5356421 | |
| 0.147 | 0.003 | 0.147 | Retinoid X alpha receptor agonist | 0.074 0.008 CID_6246154 0.074 0.008 CID_5356421 | ||
| 0.148 | 0.004 | 0.148 | Prostaglandin EP3 antagonist | 0.112 0.005 CID_6246154 0.112 0.005 CID_5356421 | ||
| 0.143 | 0.004 | 0.143 | Vanilloid 4 agonist | 0.117 0.008 CID_6246154 0.117 0.008 CID_5356421 | ||
| 0.151 | 0.012 | 0.151 | Aminopeptidase I inhibitor | 0.089 0.034 CID_6246154 0.089 0.034 CID_5356421 | ||
| 0.224 | 0.084 | 0.224 | Antiamyloidogenic | |||
| 0.141 | 0.002 | 0.141 | Prostaglandin EP4 agonist | 0.139 0.002 CID_6246154 0.139 0.002 CID_5356421 | ||
| 0.139 | 0.002 | 0.139 | Membrane dipeptidase inhibitor | 0.101 0.004 CID_6246154 0.101 0.004 CID_5356421 | ||
| 0.14 | 0.004 | 0.14 | Phospholipase D inhibitor | 0.078 0.037 CID_6246154 0.078 0.037 CID_5356421 | ||
| 0.218 | 0.082 | 0.218 | Cyclic AMP phosphodiesterase inhibitor | 0.208 0.088 CID_6246154 0.208 0.088 CID_5356421 | ||
| 0.141 | 0.005 | 0.141 | Kainate receptor antagonist | |||
| 0.14 | 0.004 | 0.14 | Prostaglandin D2 antagonist | 0.098 0.005 CID_6246154 0.098 0.005 CID_5356421 | ||
| 0.161 | 0.027 | 0.161 | Heat shock protein 70 antagonist | 0.135 0.096 CID_6246154 0.135 0.096 CID_5356421 | ||
| 0.136 | 0.003 | 0.136 | Prostacyclin agonist | 0.134 0.003 CID_6246154 0.134 0.003 CID_5356421 | ||
| 0.14 | 0.007 | 0.14 | Peroxisome proliferator-activated receptor gamma antagonist | 0.091 0.022 CID_6246154 0.091 0.022 CID_5356421 | ||
| 0.145 | 0.013 | 0.145 | Glutathione S-transferase inhibitor | 0.075 0.071 CID_6246154 0.075 0.071 CID_5356421 | ||
| 0.226 | 0.096 | 0.226 | DNA damaging | 0.204 0.112 CID_6246154 0.204 0.112 CID_5356421 | ||
| 0.139 | 0.01 | 0.139 | Bile acid receptor antagonist | 0.112 0.029 CID_6246154 0.112 0.029 CID_5356421 | ||
| 0.142 | 0.013 | 0.142 | Phenylalanine 4-hydroxylase inhibitor | 0.071 0.045 CID_6246154 0.071 0.045 CID_5356421 | ||
| 0.139 | 0.013 | 0.139 | Ribonucleoside-diphosphate reductase inhibitor | 0.082 0.024 CID_6246154 0.082 0.024 CID_5356421 | ||
| 0.145 | 0.019 | 0.145 | NADH dehydrogenase inhibitor | 0.093 0.052 CID_6246154 0.093 0.052 CID_5356421 | ||
| 0.194 | 0.069 | 0.194 | Growth factor agonist | |||
| 0.127 | 0.002 | 0.137 | Prostaglandin EP2 agonist | 0.137 0.002 CID_6246154 0.137 0.002 CID_5356421 | CID_5356421 | |
| 0.127 | 0.002 | 0.127 | Leukotriene C4 antagonist | 0.118 0.003 CID_6246154 0.118 0.003 CID_5356421 | ||
| 0.127 | 0.003 | 0.127 | Retinoid X receptor agonist | 0.095 0.005 CID_6246154 0.095 0.005 CID_5356421 | ||
| 0.145 | 0.022 | 0.145 | Cathepsin G inhibitor | 0.098 0.034 CID_6246154 0.098 0.034 CID_5356421 | ||
| 0.124 | 0.001 | 0.124 | Lysophosphatidic acid receptor 1 agonist | 0.091 0.002 CID_6246154 0.091 0.002 CID_5356421 | ||
| 0.21 | 0.087 | 0.21 | Peptidyltransferase inhibitor | 0.187 0.118 CID_6246154 0.187 0.118 CID_5356421 | ||
| 0.135 | 0.014 | 0.135 | Ribonucleotide reductase inhibitor | 0.083 0.025 CID_6246154 0.083 0.025 CID_5356421 | ||
| 0.126 | 0.006 | 0.126 | GABA B receptor agonist | 0.075 0.054 CID_6246154 0.075 0.054 CID_5356421 | ||
| 0.121 | 0.003 | 0.121 | G-protein-coupled receptor 120 agonist | 0.055 0.004 CID_6246154 0.055 0.004 CID_5356421 | ||
| 0.125 | 0.007 | 0.137 | Interferon inducer | 0.137 0.005 CID_6246154 0.137 0.005 CID_5356421 | CID_5356421 | |
| 0.129 | 0.013 | 0.129 | Cannabinoid CB1 receptor agonist | 0.121 0.014 CID_6246154 0.121 0.014 CID_5356421 | ||
| 0.138 | 0.023 | 0.138 | Interleukin 1 beta converting enzyme inhibitor | 0.101 0.056 CID_6246154 0.101 0.056 CID_5356421 | ||
| 0.143 | 0.028 | 0.143 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.129 | 0.014 | 0.129 | Lipase inhibitor | 0.071 0.053 CID_6246154 0.071 0.053 CID_5356421 | ||
| 0.139 | 0.028 | 0.139 | DOPA decarboxylase inhibitor | |||
| 0.112 | 0.001 | 0.117 | Prostaglandin F2 alpha agonist | 0.117 0.001 CID_6246154 0.117 0.001 CID_5356421 | CID_5356421 | |
| 0.113 | 0.003 | 0.116 | ATP citrate lysase inhibitor | 0.116 0.003 CID_6246154 0.116 0.003 CID_5356421 | CID_5356421 | |
| 0.113 | 0.004 | 0.113 | Peroxisome proliferator-activated receptor alpha antagonist | 0.022 0.015 CID_6246154 0.022 0.015 CID_5356421 | ||
| 0.113 | 0.004 | 0.113 | Prostacyclin antagonist | 0.085 0.005 CID_6246154 0.085 0.005 CID_5356421 | ||
| 0.12 | 0.012 | 0.12 | Elastase 1 inhibitor | 0.074 0.042 CID_6246154 0.074 0.042 CID_5356421 | ||
| 0.116 | 0.008 | 0.116 | Plasminogen activator inhibitor antagonist | |||
| 0.131 | 0.023 | 0.131 | Histidine decarboxylase inhibitor | |||
| 0.111 | 0.004 | 0.111 | Kainate receptor 2 antagonist | |||
| 0.11 | 0.004 | 0.11 | Acetyl-CoA transferase 1 inhibitor | 0.046 0.022 CID_6246154 0.046 0.022 CID_5356421 | ||
| 0.11 | 0.005 | 0.11 | Squalene synthetase inhibitor | 0.091 0.007 CID_6246154 0.091 0.007 CID_5356421 | ||
| 0.109 | 0.005 | 0.109 | Peroxisome proliferator-activated receptor delta agonist | 0.04 0.017 CID_6246154 0.04 0.017 CID_5356421 | ||
| 0.142 | 0.039 | 0.142 | Interleukin 8 antagonist | |||
| 0.137 | 0.034 | 0.137 | UDP-glucose 4-epimerase inhibitor | 0.087 0.078 CID_6246154 0.087 0.078 CID_5356421 | ||
| 0.181 | 0.079 | 0.181 | P-glycoprotein inhibitor | |||
| 0.11 | 0.009 | 0.11 | Fatty acid synthase inhibitor | 0.084 0.017 CID_6246154 0.084 0.017 CID_5356421 | ||
| 0.14 | 0.04 | 0.14 | Chelator | |||
| 0.161 | 0.06 | 0.161 | Thiol protease inhibitor | 0.146 0.073 CID_6246154 0.146 0.073 CID_5356421 | ||
| 0.112 | 0.013 | 0.112 | Prostaglandin E2 antagonist | 0.06 0.029 CID_6246154 0.06 0.029 CID_5356421 | ||
| 0.101 | 0.001 | 0.101 | Lysophosphatidic acid receptor 3 agonist | 0.077 0.002 CID_6246154 0.077 0.002 CID_5356421 | ||
| 0.102 | 0.004 | 0.102 | Leukotriene B4 receptor 1 antagonist | 0.061 0.005 CID_6246154 0.061 0.005 CID_5356421 | ||
| 0.117 | 0.018 | 0.117 | Na+ K+ transporting ATPase inhibitor | 0.105 0.027 CID_6246154 0.105 0.027 CID_5356421 | ||
| 0.104 | 0.007 | 0.104 | Sphingosine kinase inhibitor | 0.102 0.007 CID_6246154 0.102 0.007 CID_5356421 | ||
| 0.162 | 0.065 | 0.162 | Hexokinase inhibitor | |||
| 0.12 | 0.022 | 0.12 | Glutamate release inhibitor | |||
| 0.099 | 0.001 | 0.099 | Thromboxane agonist | 0.085 0.002 CID_6246154 0.085 0.002 CID_5356421 | ||
| 0.187 | 0.09 | 0.187 | Histone acetyltransferase inhibitor | |||
| 0.135 | 0.038 | 0.135 | Transcription factor STAT6 inhibitor | |||
| 0.104 | 0.008 | 0.104 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.098 | 0.002 | 0.098 | Lysophosphatidic acid 1 receptor antagonist | 0.048 0.004 CID_6246154 0.048 0.004 CID_5356421 | ||
| 0.205 | 0.11 | 0.205 | Neuropeptide Y2 antagonist | |||
| 0.122 | 0.027 | 0.122 | Interleukin 12 antagonist | |||
| 0.186 | 0.094 | 0.186 | Anticonvulsant | |||
| 0.096 | 0.004 | 0.096 | Pregnane X receptor antagonist | 0.074 0.01 CID_6246154 0.074 0.01 CID_5356421 | ||
| 0.108 | 0.017 | 0.108 | Estrogen-related receptor beta agonist | |||
| 0.099 | 0.008 | 0.099 | Sphingosine 1-phosphate receptor 3 antagonist | 0.058 0.041 CID_6246154 0.058 0.041 CID_5356421 | ||
| 0.12 | 0.029 | 0.12 | Carbonic anhydrase VI inhibitor | |||
| 0.104 | 0.014 | 0.104 | Cannabinoid CB2 receptor antagonist | |||
| 0.107 | 0.018 | 0.107 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.224 | 0.142 | 0.224 | Thyroid hormone antagonist | |||
| 0.147 | 0.064 | 0.147 | Histone deacetylase SIRT1 inhibitor | |||
| 0.11 | 0.028 | 0.163 | ATPase (Vacuolar H+) inhibitor | 0.163 0.005 CID_6246154 0.163 0.005 CID_5356421 | CID_5356421 | |
| 0.098 | 0.017 | 0.098 | Purinergic P2X1 antagonist | 0.055 0.051 CID_6246154 0.055 0.051 CID_5356421 | ||
| 0.127 | 0.045 | 0.127 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.165 | 0.084 | 0.165 | Dual specificity phosphatase 3 inhibitor | |||
| 0.088 | 0.008 | 0.088 | Acetyl-CoA transferase 2 inhibitor | 0.068 0.02 CID_6246154 0.068 0.02 CID_5356421 | ||
| 0.108 | 0.029 | 0.108 | Hematopoietic | |||
| 0.144 | 0.064 | 0.144 | Pregnane X receptor agonist | |||
| 0.083 | 0.004 | 0.083 | Glutamate (mGluR8) agonist | 0.043 0.018 CID_6246154 0.043 0.018 CID_5356421 | ||
| 0.094 | 0.015 | 0.094 | Glutamate (mGluR7) antagonist | 0.062 0.059 CID_6246154 0.062 0.059 CID_5356421 | ||
| 0.111 | 0.033 | 0.111 | Carbonic anhydrase XIII inhibitor | |||
| 0.082 | 0.004 | 0.082 | Kainate receptor 1 antagonist | |||
| 0.088 | 0.011 | 0.088 | Sphingosine kinase 2 inhibitor | 0.088 0.012 CID_6246154 0.088 0.012 CID_5356421 | ||
| 0.123 | 0.046 | 0.123 | Xanthine oxidase inhibitor | |||
| 0.091 | 0.015 | 0.091 | Autotaxin inhibitor | |||
| 0.084 | 0.008 | 0.084 | Mannosidase inhibitor | 0.062 0.015 CID_6246154 0.062 0.015 CID_5356421 | ||
| 0.08 | 0.005 | 0.08 | Geranyltranstransferase inhibitor | 0.046 0.028 CID_6246154 0.046 0.028 CID_5356421 | ||
| 0.091 | 0.017 | 0.091 | Caspase 9 inhibitor | 0.057 0.053 CID_6246154 0.057 0.053 CID_5356421 | ||
| 0.089 | 0.015 | 0.089 | Nitric oxide donor | 0.074 0.028 CID_6246154 0.074 0.028 CID_5356421 | ||
| 0.084 | 0.01 | 0.084 | Alpha-mannosidase inhibitor | 0.064 0.022 CID_6246154 0.064 0.022 CID_5356421 | ||
| 0.132 | 0.059 | 0.132 | Anesthetic local | |||
| 0.082 | 0.009 | 0.082 | Adenosine deaminase inhibitor | 0.071 0.013 CID_6246154 0.071 0.013 CID_5356421 | ||
| 0.098 | 0.026 | 0.098 | Epoxide hydrolase inhibitor | 0.085 0.037 CID_6246154 0.085 0.037 CID_5356421 | ||
| 0.109 | 0.037 | 0.109 | Phosphodiesterase 6D inhibitor | |||
| 0.088 | 0.016 | 0.088 | Exportin-1 inhibitor | 0.071 0.042 CID_6246154 0.071 0.042 CID_5356421 | ||
| 0.08 | 0.009 | 0.08 | Sphingosine 1-phosphate receptor agonist | 0.045 0.03 CID_6246154 0.045 0.03 CID_5356421 | ||
| 0.092 | 0.021 | 0.092 | NMDA receptor glycine site agonist | |||
| 0.078 | 0.007 | 0.078 | Nicotinic acid receptor agonist | 0.042 0.019 CID_6246154 0.042 0.019 CID_5356421 | ||
| 0.103 | 0.031 | 0.103 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.121 | 0.051 | 0.121 | Nav1.4 sodium channel blocker | 0.096 0.083 CID_6246154 0.096 0.083 CID_5356421 | ||
| 0.074 | 0.004 | 0.074 | Retinoid X receptor antagonist | 0.053 0.01 CID_6246154 0.053 0.01 CID_5356421 | ||
| 0.072 | 0.001 | 0.072 | Thromboxane A2 agonist | 0.06 0.002 CID_6246154 0.06 0.002 CID_5356421 | ||
| 0.082 | 0.012 | 0.082 | Lipocortins synthesis agonist | 0.063 0.03 CID_6246154 0.063 0.03 CID_5356421 | ||
| 0.091 | 0.021 | 0.091 | Carbonic anhydrase stimulant | |||
| 0.081 | 0.012 | 0.081 | CD45 antagonist | |||
| 0.081 | 0.012 | 0.081 | 5-Alpha-reductase inhibitor | |||
| 0.075 | 0.007 | 0.075 | Sphingosine 1-phosphate receptor 1 agonist | 0.051 0.019 CID_6246154 0.051 0.019 CID_5356421 | ||
| 0.135 | 0.067 | 0.135 | Toll-Like receptor antagonist | |||
| 0.093 | 0.026 | 0.093 | Glucagon-like peptide 1 agonist | |||
| 0.074 | 0.007 | 0.074 | Arginase inhibitor | 0.058 0.011 CID_6246154 0.058 0.011 CID_5356421 | ||
| 0.083 | 0.016 | 0.083 | MDM2 inhibitor | 0.074 0.03 CID_6246154 0.074 0.03 CID_5356421 | ||
| 0.068 | 0.002 | 0.068 | Carbonic anhydrase X inhibitor | 0.028 0.005 CID_6246154 0.028 0.005 CID_5356421 | ||
| 0.068 | 0.002 | 0.068 | Carbonic anhydrase VIII inhibitor | 0.028 0.005 CID_6246154 0.028 0.005 CID_5356421 | ||
| 0.208 | 0.142 | 0.208 | Hypoxia-inducible factor 1 alpha inhibitor | |||
| 0.099 | 0.034 | 0.099 | mTOR complex 2 inhibitor | |||
| 0.071 | 0.008 | 0.071 | AMPA 4 receptor antagonist | |||
| 0.126 | 0.063 | 0.126 | Adenylate cyclase inhibitor | |||
| 0.085 | 0.023 | 0.085 | Cannabinoid CB1 receptor antagonist | |||
| 0.289 | 0.228 | 0.289 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.064 | 0.003 | 0.064 | Prostaglandin H2 antagonist | 0.052 0.004 CID_6246154 0.052 0.004 CID_5356421 | ||
| 0.084 | 0.023 | 0.084 | Maillard reaction inhibitor | 0.049 0.045 CID_6246154 0.049 0.045 CID_5356421 | ||
| 0.118 | 0.058 | 0.118 | GABA receptor agonist | |||
| 0.13 | 0.071 | 0.13 | Cyclooxygenase 1 inhibitor | |||
| 0.141 | 0.082 | 0.141 | NOS3 expression enhancer | |||
| 0.069 | 0.011 | 0.069 | Cholesterol esterase inhibitor | |||
| 0.08 | 0.022 | 0.08 | GP IIb/IIIa receptor antagonist | 0.063 0.027 CID_6246154 0.063 0.027 CID_5356421 | ||
| 0.065 | 0.007 | 0.065 | Glutamate (mGluR3) antagonist | |||
| 0.062 | 0.004 | 0.062 | Retinoid X alpha receptor antagonist | 0.044 0.011 CID_6246154 0.044 0.011 CID_5356421 | ||
| 0.062 | 0.004 | 0.062 | Free fatty acid receptor 1 agonist | 0.018 0.012 CID_6246154 0.018 0.012 CID_5356421 | ||
| 0.103 | 0.046 | 0.103 | ABCA1 expression enhancer | 0.091 0.065 CID_6246154 0.091 0.065 CID_5356421 | ||
| 0.09 | 0.033 | 0.09 | Cannabinoid receptor antagonist | |||
| 0.071 | 0.014 | 0.071 | HCV NS3/NS4A protease inhibitor | |||
| 0.07 | 0.015 | 0.07 | Purinergic P2Y antagonist | |||
| 0.071 | 0.016 | 0.071 | Ryanodine receptor antagonist | 0.058 0.045 CID_6246154 0.058 0.045 CID_5356421 | ||
| 0.062 | 0.008 | 0.062 | Sphingosine kinase 1 inhibitor | 0.06 0.009 CID_6246154 0.06 0.009 CID_5356421 | ||
| 0.057 | 0.003 | 0.057 | Calcium-independent phospholipase A2 inhibitor | 0.057 0.003 CID_6246154 0.057 0.003 CID_5356421 | ||
| 0.058 | 0.004 | 0.058 | Leukotriene B4 receptor 2 antagonist | 0.034 0.007 CID_6246154 0.034 0.007 CID_5356421 | ||
| 0.058 | 0.005 | 0.058 | HMG CoA reductase inhibitor | 0.051 0.007 CID_6246154 0.051 0.007 CID_5356421 | ||
| 0.064 | 0.011 | 0.064 | Factor XIIIa inhibitor | 0.034 0.03 CID_6246154 0.034 0.03 CID_5356421 | ||
| 0.062 | 0.009 | 0.062 | GABA uptake inhibitor | |||
| 0.075 | 0.023 | 0.075 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.068 | 0.015 | 0.068 | Squalene epoxidase inhibitor | 0.046 0.042 CID_6246154 0.046 0.042 CID_5356421 | ||
| 0.057 | 0.005 | 0.057 | Vanilloid 3 antagonist | |||
| 0.095 | 0.043 | 0.095 | Topoisomerase II alpha inhibitor | |||
| 0.14 | 0.089 | 0.142 | Anticoagulant | 0.142 0.088 CID_6246154 0.142 0.088 CID_5356421 | CID_5356421 | |
| 0.112 | 0.061 | 0.112 | Acetylcholine release stimulant | |||
| 0.057 | 0.006 | 0.057 | Glutamate (mGluR8) antagonist | 0.042 0.015 CID_6246154 0.042 0.015 CID_5356421 | ||
| 0.062 | 0.013 | 0.062 | AICAR transformylase inhibitor | 0.045 0.028 CID_6246154 0.045 0.028 CID_5356421 | ||
| 0.201 | 0.153 | 0.201 | Thyroid hormone beta antagonist | |||
| 0.061 | 0.013 | 0.061 | Glutamate (mGluR4) antagonist | |||
| 0.065 | 0.016 | 0.065 | Heparanase inhibitor | 0.056 0.03 CID_6246154 0.056 0.03 CID_5356421 | ||
| 0.052 | 0.004 | 0.052 | Glutamate (mGluR3) agonist | 0.03 0.028 CID_6246154 0.03 0.028 CID_5356421 | ||
| 0.054 | 0.007 | 0.054 | Lysine carboxypeptidase inhibitor | |||
| 0.051 | 0.004 | 0.051 | Elastase 3B inhibitor | 0.037 0.011 CID_6246154 0.037 0.011 CID_5356421 | ||
| 0.051 | 0.004 | 0.051 | Elastase 3A inhibitor | 0.037 0.011 CID_6246154 0.037 0.011 CID_5356421 | ||
| 0.051 | 0.004 | 0.051 | Elastase 2B inhibitor | 0.037 0.011 CID_6246154 0.037 0.011 CID_5356421 | ||
| 0.062 | 0.016 | 0.062 | Thymidylate synthase inhibitor | |||
| 0.048 | 0.003 | 0.048 | Retinoid X beta receptor antagonist | 0.027 0.005 CID_6246154 0.027 0.005 CID_5356421 | ||
| 0.094 | 0.049 | 0.227 | Antineoplastic antibiotic | 0.227 0.017 CID_6246154 0.227 0.017 CID_5356421 | CID_5356421 | |
| 0.054 | 0.009 | 0.06 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | 0.06 0.007 CID_6246154 0.06 0.007 CID_5356421 | CID_5356421 | |
| 0.047 | 0.003 | 0.047 | Calcium-dependent phospholipase A2 inhibitor | 0.018 0.005 CID_6246154 0.018 0.005 CID_5356421 | ||
| 0.052 | 0.008 | 0.052 | Free fatty acid receptor 1 antagonist | |||
| 0.067 | 0.024 | 0.067 | Glucosylceramidase inhibitor | |||
| 0.049 | 0.007 | 0.049 | Purinergic P2Y12 antagonist | |||
| 0.13 | 0.088 | 0.13 | Cyclooxygenase inhibitor | |||
| 0.058 | 0.016 | 0.058 | Leukotriene A4 hydrolase inhibitor | |||
| 0.05 | 0.008 | 0.05 | Integrin alpha1beta1 antagonist | |||
| 0.079 | 0.038 | 0.079 | Potassium channel (Tandem pore domain) blocker | |||
| 0.113 | 0.072 | 0.113 | Proteasome inhibitor | |||
| 0.063 | 0.023 | 0.063 | Adenine nucleotide translocase inhibitor | |||
| 0.073 | 0.033 | 0.073 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.055 | 0.015 | 0.055 | G protein-coupled receptor agonist | |||
| 0.063 | 0.024 | 0.063 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.053 | 0.014 | 0.053 | Cholecystokinin B agonist | |||
| 0.043 | 0.005 | 0.043 | Glutamate (mGluR1a) agonist | |||
| 0.067 | 0.029 | 0.067 | Carbonic anhydrase VB inhibitor | |||
| 0.042 | 0.004 | 0.042 | Vanilloid 2 agonist | 0.036 0.005 CID_6246154 0.036 0.005 CID_5356421 | ||
| 0.055 | 0.017 | 0.055 | Guanylate cyclase inhibitor | |||
| 0.087 | 0.05 | 0.087 | D-Ala-D-Ala ligase inhibitor | |||
| 0.048 | 0.011 | 0.048 | Peptide deformylase inhibitor | |||
| 0.112 | 0.075 | 0.112 | Beta amyloid protein antagonist | |||
| 0.054 | 0.017 | 0.054 | Glutamate (mGluR group III) antagonist | |||
| 0.051 | 0.014 | 0.051 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | |||
| 0.048 | 0.011 | 0.048 | VCAM-1 antagonist | |||
| 0.047 | 0.011 | 0.047 | VCAM antagonist | |||
| 0.041 | 0.005 | 0.041 | Glutamate (mGluR1) agonist | |||
| 0.039 | 0.003 | 0.039 | Vitamin D receptor agonist | 0.026 0.004 CID_6246154 0.026 0.004 CID_5356421 | ||
| 0.051 | 0.016 | 0.051 | Angiotensin AT1 receptor antagonist | |||
| 0.175 | 0.14 | 0.175 | Nitric-oxide synthase stimulant | |||
| 0.085 | 0.05 | 0.085 | Thioredoxin reductase inhibitor | |||
| 0.059 | 0.025 | 0.059 | Integrin antagonist | |||
| 0.049 | 0.015 | 0.049 | Farnesoid X receptor agonist | |||
| 0.04 | 0.007 | 0.04 | Retinoid X gamma receptor agonist | 0.034 0.009 CID_6246154 0.034 0.009 CID_5356421 | ||
| 0.041 | 0.008 | 0.041 | Prostaglandin EP1 antagonist | 0.023 0.012 CID_6246154 0.023 0.012 CID_5356421 | ||
| 0.042 | 0.009 | 0.042 | Kynurenine 3 monooxygenase inhibitor | |||
| 0.074 | 0.042 | 0.074 | Carbonic anhydrase VA inhibitor | |||
| 0.054 | 0.021 | 0.054 | Leukocyte elastase inhibitor | |||
| 0.088 | 0.056 | 0.088 | Antineoplastic alkaloid | |||
| 0.037 | 0.006 | 0.037 | Retinoid X gamma receptor antagonist | 0.033 0.009 CID_6246154 0.033 0.009 CID_5356421 | ||
| 0.05 | 0.019 | 0.05 | GABA B receptor antagonist | |||
| 0.067 | 0.037 | 0.067 | NMDA 2C receptor antagonist | |||
| 0.042 | 0.012 | 0.042 | AMPA 3 receptor antagonist | |||
| 0.036 | 0.007 | 0.036 | Nicotinic acid receptor 2 antagonist | |||
| 0.047 | 0.018 | 0.047 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.042 | 0.013 | 0.042 | Glucagon receptor antagonist | |||
| 0.084 | 0.055 | 0.084 | Inducible nitric-oxide synthase inhibitor | |||
| 0.067 | 0.039 | 0.067 | Beta 3 adrenoreceptor antagonist | |||
| 0.059 | 0.031 | 0.059 | Angiotensin-converting enzyme inhibitor | 0.056 0.036 CID_6246154 0.056 0.036 CID_5356421 | ||
| 0.04 | 0.012 | 0.04 | Carboxypeptidase B inhibitor | |||
| 0.036 | 0.008 | 0.036 | 5-Alpha-reductase 2 inhibitor | |||
| 0.04 | 0.012 | 0.04 | Uridine phosphorylase inhibitor | |||
| 0.044 | 0.017 | 0.044 | Phosphoglycerate kinase inhibitor | |||
| 0.056 | 0.029 | 0.056 | Prolyl endopeptidase inhibitor | |||
| 0.041 | 0.014 | 0.041 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.056 | 0.029 | 0.056 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.052 | 0.025 | 0.052 | Microtubule stabilization | 0.042 0.038 CID_6246154 0.042 0.038 CID_5356421 | ||
| 0.03 | 0.005 | 0.039 | Isoleucine-tRNA ligase inhibitor | 0.039 0.003 CID_6246154 0.039 0.003 CID_5356421 | CID_5356421 | |
| 0.051 | 0.026 | 0.051 | Cytokine production stimulant | 0.048 0.035 CID_6246154 0.048 0.035 CID_5356421 | ||
| 0.086 | 0.061 | 0.086 | Interleukin 5 antagonist | |||
| 0.038 | 0.013 | 0.038 | Epoxide hydrolase 1 inhibitor | |||
| 0.032 | 0.008 | 0.032 | Retinoid X beta receptor agonist | 0.027 0.009 CID_6246154 0.027 0.009 CID_5356421 | ||
| 0.029 | 0.005 | 0.029 | Ileal bile acid transport inhibitor | 0.018 0.011 CID_6246154 0.018 0.011 CID_5356421 | ||
| 0.078 | 0.054 | 0.078 | Metalloproteinase-2 inhibitor | |||
| 0.029 | 0.005 | 0.029 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.049 | 0.025 | 0.049 | Macrophage elastase inhibitor | |||
| 0.042 | 0.019 | 0.042 | Calcitonin receptor agonist | |||
| 0.045 | 0.021 | 0.045 | Dihydropteroate synthase inhibitor | |||
| 0.033 | 0.01 | 0.033 | Thyroid hormone agonist | |||
| 0.028 | 0.005 | 0.028 | Neuraminidase (Influenza B) inhibitor | 0.025 0.008 CID_6246154 0.025 0.008 CID_5356421 | ||
| 0.039 | 0.016 | 0.039 | Angiotensin II receptor antagonist | |||
| 0.077 | 0.054 | 0.077 | Estrogen receptor alpha antagonist | |||
| 0.049 | 0.026 | 0.049 | NMDA receptor subunit 3B antagonist | |||
| 0.066 | 0.044 | 0.066 | Cannabinoid receptor agonist | 0.057 0.051 CID_6246154 0.057 0.051 CID_5356421 | ||
| 0.053 | 0.03 | 0.053 | Bombesin 2 receptor antagonist | |||
| 0.043 | 0.021 | 0.043 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.067 | 0.045 | 0.067 | Carbonic anhydrase V inhibitor | |||
| 0.048 | 0.027 | 0.048 | Neuraminidase (Influenza A) inhibitor | 0.045 0.032 CID_6246154 0.045 0.032 CID_5356421 | ||
| 0.029 | 0.009 | 0.029 | 5-Alpha-reductase 1 inhibitor | |||
| 0.024 | 0.004 | 0.024 | Glutamate (mGluR6) agonist | |||
| 0.17 | 0.151 | 0.17 | Cardiotonic | |||
| 0.055 | 0.035 | 0.055 | Aldose reductase inhibitor | |||
| 0.023 | 0.004 | 0.023 | Carbonic anhydrase XI inhibitor | |||
| 0.039 | 0.019 | 0.039 | Ceramide glucosyltransferase inhibitor | |||
| 0.075 | 0.056 | 0.075 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.051 | 0.032 | 0.051 | Carbonic anhydrase XIV inhibitor | |||
| 0.031 | 0.012 | 0.031 | Hedgehog signaling activator | |||
| 0.043 | 0.024 | 0.043 | Dopamine D5 agonist | |||
| 0.03 | 0.011 | 0.03 | Toll-Like receptor 4 agonist | 0.026 0.02 CID_6246154 0.026 0.02 CID_5356421 | ||
| 0.042 | 0.024 | 0.042 | NMDA receptor subunit 3A antagonist | |||
| 0.023 | 0.005 | 0.023 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 CID_6246154 0.019 0.011 CID_5356421 | ||
| 0.096 | 0.078 | 0.096 | Factor V inhibitor | |||
| 0.092 | 0.074 | 0.092 | Nitric-oxide synthase inhibitor | |||
| 0.137 | 0.119 | 0.137 | Amyloid beta aggregation inhibitor | |||
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | |||
| 0.08 | 0.062 | 0.08 | Caspase 7 inhibitor | |||
| 0.025 | 0.008 | 0.025 | Aminopeptidase A inhibitor | |||
| 0.074 | 0.057 | 0.074 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.035 | 0.018 | 0.035 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.031 | 0.014 | 0.031 | 1,3-Beta-glucan synthase inhibitor | 0.028 0.021 CID_6246154 0.028 0.021 CID_5356421 | ||
| 0.094 | 0.077 | 0.094 | Falcipain 3 inhibitor | |||
| 0.068 | 0.051 | 0.068 | Prostaglandin-E synthase inhibitor | |||
| 0.06 | 0.044 | 0.06 | TRPA1 antagonist | |||
| 0.041 | 0.025 | 0.041 | Retinoic acid alpha receptor agonist | |||
| 0.035 | 0.019 | 0.035 | Caspase 2 inhibitor | |||
| 0.036 | 0.02 | 0.036 | Carnitine palmitoyltransferase inhibitor | |||
| 0.022 | 0.007 | 0.022 | Thyroid hormone alpha antagonist | |||
| 0.024 | 0.008 | 0.024 | Caspase 8 inhibitor | |||
| 0.039 | 0.023 | 0.039 | Inosine monophosphate dehydrogenase inhibitor | |||
| 0.041 | 0.025 | 0.041 | Urate transporter 1 inhibitor | |||
| 0.031 | 0.015 | 0.031 | Purinergic P2Y15 antagonist | 0.026 0.025 CID_6246154 0.026 0.025 CID_5356421 | ||
| 0.048 | 0.035 | 0.048 | Metalloproteinase-3 inhibitor | |||
| 0.035 | 0.022 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.024 | 0.012 | 0.025 | Integrin alphaVbeta3 antagonist | 0.025 0.012 CID_6246154 0.025 0.012 CID_5356421 | CID_5356421 | |
| 0.053 | 0.041 | 0.053 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.022 | 0.01 | 0.022 | Toll-Like receptor 8 agonist | |||
| 0.024 | 0.013 | 0.024 | Elastase 2A inhibitor | |||
| 0.024 | 0.013 | 0.024 | Elastase 2 inhibitor | |||
| 0.016 | 0.004 | 0.016 | Calcineurin inhibitor | |||
| 0.091 | 0.08 | 0.091 | Glutamate (mGluR7) agonist | |||
| 0.037 | 0.026 | 0.054 | Histone deacetylase 7 inhibitor | 0.054 0.017 CID_6246154 0.054 0.017 CID_5356421 | CID_5356421 | |
| 0.113 | 0.102 | 0.113 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.061 | 0.05 | 0.061 | Neuraminidase (influenza) inhibitor | |||
| 0.058 | 0.046 | 0.058 | Neuraminidase inhibitor | |||
| 0.04 | 0.029 | 0.04 | Thymidine kinase inhibitor | |||
| 0.07 | 0.059 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.019 | 0.009 | 0.019 | Telomerase stimulant | |||
| 0.021 | 0.011 | 0.021 | Retinoic acid beta receptor agonist | |||
| 0.024 | 0.015 | 0.024 | Retinoic acid receptor agonist | |||
| 0.053 | 0.043 | 0.053 | Dihydroorotate oxidase inhibitor | |||
| 0.014 | 0.005 | 0.014 | Immunosuppressant Cyclosporine-like | 0.011 0.009 CID_6246154 0.011 0.009 CID_5356421 | ||
| 0.048 | 0.039 | 0.065 | Potassium channel (Inward rectifier) activator | 0.065 0.015 CID_6246154 0.065 0.015 CID_5356421 | CID_5356421 | |
| 0.129 | 0.12 | 0.129 | CF transmembrane conductance regulator agonist | |||
| 0.028 | 0.019 | 0.028 | LFA antagonist | |||
| 0.042 | 0.034 | 0.042 | Dihydrofolate reductase inhibitor | |||
| 0.023 | 0.014 | 0.023 | Retinoic acid gamma receptor agonist | |||
| 0.046 | 0.038 | 0.062 | Potassium channel (ATP-sensitive) activator | 0.062 0.014 CID_6246154 0.062 0.014 CID_5356421 | CID_5356421 | |
| 0.027 | 0.019 | 0.027 | Urotensin II agonist | |||
| 0.023 | 0.015 | 0.023 | ICAM 1 antagonist | |||
| 0.028 | 0.021 | 0.028 | Liver X receptor beta antagonist | |||
| 0.022 | 0.015 | 0.022 | Purinergic P2T antagonist | |||
| 0.015 | 0.008 | 0.015 | Integrin beta6 antagonist | |||
| 0.024 | 0.018 | 0.024 | Kainate receptor 4 antagonist | |||
| 0.022 | 0.015 | 0.022 | Geranylgeranyltransferase inhibitor | |||
| 0.027 | 0.02 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | |||
| 0.041 | 0.037 | 0.041 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.013 | 0.009 | 0.013 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.026 | 0.023 | 0.026 | AMPA 1 receptor antagonist | |||
| 0.013 | 0.01 | 0.013 | Angiotensin AT1B receptor antagonist | |||
| 0.007 | 0.005 | 0.007 | Phosphoribosylglycinamide formyltransferase inhibitor | |||
| 0.057 | 0.055 | 0.057 | Neutrophil collagenase inhibitor | |||
| 0.021 | 0.018 | 0.021 | Vitamin D receptor antagonist | |||
| 0.05 | 0.048 | 0.05 | DNA helicase inhibitor | |||
| 0.055 | 0.053 | 0.055 | HIV-1 integrase (3'-Processing) inhibitor | |||
| 0.015 | 0.012 | 0.015 | Purinergic P2Y1 agonist | |||
| 0.053 | 0.051 | 0.053 | Androgen agonist | |||
| 0.088 | 0.086 | 0.088 | Carbonic anhydrase XV inhibitor | |||
| 0.073 | 0.071 | 0.073 | ErbB-3 antagonist | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.051 | 0.049 | 0.051 | HIV-1 integrase (Strand Transfer) inhibitor | |||
| 0.036 | 0.035 | 0.036 | Histone deacetylase 9 inhibitor | 0.036 0.034 CID_6246154 0.036 0.034 CID_5356421 | ||
| 0.026 | 0.027 | 0.041 | Histone deacetylase class IV inhibitor | 0.041 0.017 CID_6246154 0.041 0.017 CID_5356421 | CID_5356421 | |
| 0.026 | 0.027 | 0.041 | Histone deacetylase 11 inhibitor | 0.041 0.017 CID_6246154 0.041 0.017 CID_5356421 | CID_5356421 | |
| 0.081 | 0.084 | 0.09 | Protease inhibitor | 0.09 0.074 CID_6246154 0.09 0.074 CID_5356421 | CID_5356421 | |
| 0.097 | 0.106 | 0.11 | Estrogen antagonist | 0.11 0.074 CID_6246154 0.11 0.074 CID_5356421 | CID_5356421 | |
| 0.02 | 0.029 | 0.039 | Histone deacetylase 10 inhibitor | 0.039 0.016 CID_6246154 0.039 0.016 CID_5356421 | CID_5356421 | |
| 0.04 | 0.053 | 0.053 | Protein 50S ribosomal subunit inhibitor | 0.053 0.036 CID_6246154 0.053 0.036 CID_5356421 | CID_5356421 | |
| 0.059 | 0.121 | 0.094 | Bronchodilator | 0.094 0.071 CID_6246154 0.094 0.071 CID_5356421 | CID_5356421 | |
| 0.015 | 0.134 | 0.045 | HIV-1 protease inhibitor | 0.045 0.027 CID_6246154 0.045 0.027 CID_5356421 | CID_5356421 | |
| 0.044 | 0.204 | 0.134 | Aminoacyl-tRNA synthetase inhibitor | 0.134 0.024 CID_6246154 0.134 0.024 CID_5356421 | CID_5356421 | |
| 0.008 | 0.197 | 0.061 | Glucocorticoid antagonist | 0.061 0.011 CID_6246154 0.061 0.011 CID_5356421 | CID_5356421 | |
| 0.099 | 0.336 | 0.675 | Angiogenesis inhibitor | 0.675 0.01 CID_6246154 0.675 0.01 CID_5356421 | CID_5356421 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |